8.4 Routine Antepartum Surveillance, Nutritional Needs & Weight Gain Guidelines
Key Takeaways
The standard antepartum visit cadence for uncomplicated pregnancies is every 4 weeks until 28 weeks of gestation, every 2 weeks from 28 to 36 weeks, and weekly from 36 weeks until birth.
Fundal height measured in centimeters using McDonald's rule (from symphysis pubis to fundus) correlates closely with gestational age between 20 and 36 weeks; a discrepancy of ±2 to 3 cm indicates a size-dates discrepancy warranting diagnostic ultrasound evaluation.
Recommended gestational weight gain is determined strictly by pre-pregnancy BMI: Underweight (<18.5) 28–40 lbs; Normal weight (18.5–24.9) 25–35 lbs; Overweight (25.0–29.9) 15–25 lbs; Obese (≥30.0) 11–20 lbs.
Essential nutritional requirements during pregnancy include an additional ~340 to 450 kcal/day in the second and third trimesters, 27 mg/day of elemental iron, 1,000 mg/day of calcium, and 200 to 300 mg/day of DHA omega-3 fatty acids, alongside avoidance of high-mercury fish and unpasteurized foods.
Routine antenatal screening follows a standardized chronological timeline: first-trimester screening/cfDNA (11–13 6/7 weeks), anatomic survey ultrasound (18–20 6/7 weeks), gestational diabetes screening, repeat CBC, and Rh antibody screen with RhoGAM administration (24–28 weeks), Tdap vaccination (27–36 weeks), and universal rectovaginal Group B Streptococcus (GBS) culture (36 0/7–37 6/7 weeks; ACOG 2020).
Antepartum Visit Cadence & Routine Surveillance
Routine antepartum care monitors maternal-fetal well-being, provides anticipatory guidance, detects obstetric complications early, and optimizes perinatal outcomes. For a healthy, uncomplicated singleton pregnancy, visits adhere to a standardized schedule.
Routine Visit Frequency Schedule
- Conception to 28 0/7 Weeks: Every 4 weeks.
- 28 1/7 to 36 0/7 Weeks: Every 2 weeks.
- 36 1/7 Weeks to Delivery: Weekly until birth.
- High-Risk Deviations: Complications such as chronic hypertension, gestational diabetes, multiple gestation, or fetal growth restriction require intensified surveillance intervals and individualized fetal assessment.
Clinical Assessments Performed at Every Visit
- Maternal Blood Pressure: Evaluated using an appropriately sized cuff with the patient seated and rested. Blood pressure ≥140 mmHg systolic or ≥90 mmHg diastolic documented on two occasions at least 4 hours apart after 20 weeks indicates gestational hypertension or preeclampsia.
- Maternal Weight & Weight Gain Tracking: Measured and plotted against the Institute of Medicine (IOM) gestational weight gain curves.
- Urine Assessment (Selective vs. Universal): Screened via dipstick for proteinuria (evaluating preeclampsia) and glucosuria (reflecting filtered glucose exceeding tubular reabsorptive thresholds).
- Fetal Heart Tones (FHT): Evaluated via handheld Doppler from 10 to 12 weeks onward; normal baseline heart rate is 110 to 160 beats per minute.
- Fundal Height Measurement (McDonald's Rule): Performed at every visit starting at 20 weeks.
- Fetal Movement Assessment (Kick Counts): Assessed starting at 28 weeks.
McDonald's Rule & Fundal Height Surveillance
Fundal height measurement is a non-invasive screening tool for fetal growth and amniotic fluid volume.
Technique & Anatomical Landmarks
- Technique: With the patient in a supine position and an empty urinary bladder, a non-elastic tape measure is placed at the superior border of the pubic symphysis and extended over the midline contour of the abdomen to the top of the uterine fundus.
- Anatomical Milestones:
- 12 Weeks: Uterine fundus palpable just above the pubic symphysis.
- 16 Weeks: Uterine fundus midway between the pubic symphysis and the umbilicus.
- 20 Weeks: Uterine fundus reaches the level of the umbilicus (approximately 20 cm).
- 20 to 36 Weeks: The fundal height measurement in centimeters corresponds roughly to the gestational age in weeks (±2 to 3 cm).
- After 36 Weeks: Fundal height may drop slightly as the fetal presenting part engages into the true pelvis ("lightening").
Evaluating Size-Dates Discrepancy
A discrepancy of greater than 2 to 3 cm between the fundal height measurement and the established gestational age in weeks constitutes a size-dates discrepancy that mandates diagnostic obstetric ultrasonography.
- Size Greater than Dates (Fundal Height > GA by ≥3 cm):
- Differential Diagnosis: Inaccurate dating / mistaken LMP, multiple gestation, fetal macrosomia, polyhydramnios, maternal obesity, uterine leiomyomas (fibroids), or full maternal bladder.
- Size Less than Dates (Fundal Height < GA by ≥3 cm):
- Differential Diagnosis: Inaccurate dating, fetal growth restriction (FGR / IUGR), oligohydramnios, fetal demise, transverse fetal lie, or early fetal engagement.
Fetal Movement Counting (Kick Counts)
Starting at 28 weeks of gestation, daily fetal movement monitoring is recommended. The standard ACOG-endorsed protocol instructs the patient to rest quietly in a recumbent or left lateral tilt position and track fetal movements:
- Target Threshold: 10 distinct fetal movements (kicks, flutters, rolls) within a 2-hour window.
- Clinical Action for Decreased Fetal Movement: If fewer than 10 movements are felt within 2 hours or the patient perceives a marked deviation from baseline activity, the patient must present immediately for urgent fetal assessment: an antepartum Non-Stress Test (NST) and sonographic evaluation of amniotic fluid volume (AFI) or full Biophysical Profile (BPP).
Gestational Weight Gain Guidelines (Institute of Medicine)
In 2009, the Institute of Medicine (IOM) and National Research Council established weight gain targets categorized strictly by the patient's pre-pregnancy Body Mass Index (BMI).
| Pre-Pregnancy BMI Category | Pre-Pregnancy BMI (kg/m²) | Total Recommended Weight Gain (Singleton) | Second & Third Trimester Weekly Rate of Gain |
|---|---|---|---|
| Underweight | <18.5 | 28 to 40 lbs (12.5 to 18.0 kg) | ~1.0 lb / week (0.45 kg / week) |
| Normal Weight | 18.5 to 24.9 | 25 to 35 lbs (11.5 to 16.0 kg) | ~1.0 lb / week (0.42 kg / week) |
| Overweight | 25.0 to 29.9 | 15 to 25 lbs (7.0 to 11.5 kg) | ~0.6 lb / week (0.28 kg / week) |
| Obese (All Classes) | ≥30.0 | 11 to 20 lbs (5.0 to 9.0 kg) | ~0.5 lb / week (0.22 kg / week) |
Important
First-trimester gestational weight gain is minimal across all BMI categories: typically 1.1 to 4.4 lbs (0.5 to 2.0 kg) total. Weight gain should accelerate predictably in the second and third trimesters. Inadequate weight gain increases the risk of intrauterine growth restriction and preterm birth, whereas excessive gain significantly elevates risks of gestational diabetes, preeclampsia, failed labor induction, cesarean delivery, and fetal macrosomia.
Maternal Nutritional Requirements & Dietary Safety
Pregnancy demands increased macro- and micronutrients to sustain the expanding maternal plasma volume, growing fetoplacental unit, and mammary tissue.
Caloric Requirements
- First Trimester: No increase in caloric intake (0 additional kcal/day).
- Second Trimester: Increase of approximately 340 kcal/day above baseline.
- Third Trimester: Increase of approximately 452 kcal/day above baseline (an average increase of ~300 kcal/day across the latter half of gestation).
Essential Micronutrients
- Elemental Iron (27 mg/day): Supports maternal red blood cell mass expansion (450 mL) and fetal-placental erythropoiesis. Supplementation prevents maternal iron deficiency anemia, which is associated with low birth weight, preterm birth, and postpartum hemorrhage.
- Elemental Calcium (1,000 mg/day; 1,300 mg/day for adolescents aged 14–18): Essential for fetal bone and tooth mineralization. Maternal intestinal calcium absorption doubles early in gestation; if dietary intake is inadequate, calcium is resorbed from maternal skeletal stores.
- Folic Acid (400 to 800 mcg/day): Continued throughout gestation for cell division, placental growth, and erythropoiesis.
- Omega-3 Fatty Acids (DHA 200–300 mg/day): Docosahexaenoic acid (DHA) is essential for fetal brain development and retinal photoreceptor synaptogenesis.
- Iodine (150–220 mcg/day): Critical for maternal and fetal thyroid hormone synthesis; severe deficiency impairs neurocognitive development.
- Vitamin D (600 IU/day): Promotes calcium absorption and skeletal homeostasis.
Critical Dietary Safety & Foodborne Pathogen Avoidance
- Listeria monocytogenes: Transplacental infection causes chorioamnionitis, spontaneous abortion, stillbirth, and neonatal sepsis. Patients must avoid unpasteurized milk and soft cheeses (feta, brie, camembert, queso fresco, blue-veined cheeses), unpasteurized juices, and refrigerated pâtés. Deli cold cuts and hot dogs must be heated until steaming hot (165°F) before consumption.
- Methylmercury: Bioaccumulates in apex predatory fish and causes irreversible fetal neurotoxicity. Patients must avoid shark, swordfish, king mackerel, bigeye tuna, marlin, and tilefish. Encourage 8 to 12 ounces per week of low-mercury fish (salmon, canned light tuna, shrimp, pollock, cod, tilapia).
- Toxoplasma gondii: Causes congenital toxoplasmosis (chorioretinitis, hydrocephalus, intracranial calcifications). Avoid raw or undercooked meats, unwashed fruits/vegetables, and cleaning cat litter boxes.
Chronological Antenatal Screening Timeline
Standard antepartum care follows an evidence-based chronological schedule of diagnostic and screening interventions.
| Gestational Age Window | Clinical Screening / Diagnostic Procedure | Clinical Indication & Management |
|---|---|---|
| 11 0/7 to 13 6/7 Weeks | First-Trimester Aneuploidy Screening OR Cell-Free DNA (cfDNA / NIPT) | • First-Trimester Screen: Nuchal translucency (NT) ultrasound + maternal serum PAPP-A and free beta-hCG (screens for trisomies 21 and 18). • cfDNA: Evaluates maternal circulating fetal cell-free DNA (available anytime after 9–10 weeks); highest sensitivity (>99%) and lowest false-positive rate for trisomy 21. |
| 18 0/7 to 20 6/7 Weeks | Detailed Fetal Anatomy Survey Ultrasound | • Comprehensive structural survey: evaluates cranial anatomy, heart (4-chamber view and outflow tracts), spine, stomach, kidneys, bladder, abdominal wall, extremities, umbilical cord vessels, and placental localization (ruling out placenta previa). |
| 24 0/7 to 28 6/7 Weeks | Gestational Diabetes Screening (1-Hour 50g GCT) | • Non-fasting screening test; serum glucose measured 1 hour after oral 50g glucose load. • Plasma glucose ≥135 or ≥140 mg/dL is elevated, indicating need for diagnostic 3-hour 100g oral glucose tolerance test (OGTT). |
| 24 0/7 to 28 6/7 Weeks | Repeat CBC & Hemoglobin/Hematocrit | • Identifies physiological hemodilution vs. emerging iron deficiency anemia requiring therapeutic iron supplementation. |
| 28 0/7 Weeks | Repeat Antibody Screen & RhoGAM Administration | • In Rh(D)-negative, unsensitized gravidas, repeat indirect Coombs antibody screen is drawn. • Administer 300 mcg anti-D immune globulin (RhoGAM) intramuscularly at 28 weeks to prevent alloimmunization. |
| 27 0/7 to 36 6/7 Weeks | Tdap (Tetanus, Diphtheria, Pertussis) Vaccination | • Administered during EACH AND EVERY pregnancy, regardless of prior vaccination history (optimal window 27–36 weeks, typically given at 28 weeks). • Induces high maternal IgG pertussis antibodies that cross the placenta to provide passive neonatal immunity against severe whooping cough. |
| 36 0/7 to 37 6/7 Weeks | Universal Rectovaginal Group B Streptococcus (GBS) Culture | • Swab lower vaginal introitus and rectum through anal sphincter. • If positive, administer intrapartum intravenous antibiotic prophylaxis (IV Penicillin G) at onset of labor or membrane rupture to prevent neonatal early-onset GBS sepsis, pneumonia, and meningitis. |
A 28-year-old primigravida at 10 weeks of gestation presents for her second antepartum visit. Her pre-pregnancy weight was 165 lbs and her height is 5 feet 4 inches, yielding a pre-pregnancy Body Mass Index (BMI) of 28.3 kg/m² (overweight). She asks the WHNP for guidance regarding how much total weight she should aim to gain over the course of her singleton pregnancy. Based on the Institute of Medicine (IOM) guidelines, what is the recommended total gestational weight gain for this patient?
28 to 40 lbs (12.5 to 18.0 kg)
25 to 35 lbs (11.5 to 16.0 kg)
11 to 20 lbs (5.0 to 9.0 kg)
15 to 25 lbs (7.0 to 11.5 kg)
A 31-year-old multigravida at 32 weeks of gestation presents for a routine prenatal visit. Her pregnancy has been uncomplicated, and previous first-trimester ultrasound confirmed accurate dating. Upon examination, McDonald's fundal height measurement is 28 cm, verified twice using standard technique with an empty urinary bladder. The fetal heart rate is 140 beats per minute. What is the most appropriate next step in clinical management?
Reassure the patient that fundal height normally varies by up to 5 cm in the third trimester and re-evaluate at the next routine visit in 2 weeks.
Order an obstetric ultrasound to assess fetal biometry, estimated fetal weight, and amniotic fluid volume for a size-dates discrepancy.
Admit the patient to labor and delivery immediately for emergency induction of labor due to suspected acute oligohydramnios.
Perform a 1-hour glucose challenge test to screen for atypical late-onset gestational diabetes.
A 25-year-old primigravida at 28 weeks of gestation presents for a routine antepartum visit. Her blood type is A-negative with a negative indirect Coombs antibody screen documented at her initial prenatal visit. She received a tetanus, diphtheria, and acellular pertussis (Tdap) vaccine 2 years ago following a laceration injury. How should the WHNP manage her immunoprophylaxis and vaccinations during today's visit?
Administer 300 mcg of anti-D immune globulin (RhoGAM) today, but omit the Tdap vaccine because she received a documented booster within the past 5 years.
Defer anti-D immune globulin until delivery, and administer the Tdap vaccine today.
Administer 300 mcg of anti-D immune globulin (RhoGAM) and administer the Tdap vaccine today, counseling that Tdap is recommended during every pregnancy.
Administer 50 mcg of anti-D immune globulin (RhoGAM) today and defer the Tdap vaccine until the immediate postpartum period.
Sections you finish are checked off in the contents.